American Capital Advisory’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$354 Buy
+3
New +$419 ﹤0.01% 931
2025
Q3
Sell
-2
Closed -$249 1043
2025
Q2
$249 Buy
+2
New +$255 ﹤0.01% 771

Other funds holding RGEN

American Capital Advisory's RGEN Position: Q1 2026 in Review

American Capital Advisory opened a new position in Repligen (RGEN) in Q1 2026: 3 shares worth $354. The stake represents ﹤0.01% of the portfolio and ranks #931 among its holdings. This is a return to the name: American Capital Advisory previously reported a position in RGEN as recently as Q2 2025.

American Capital Advisory first reported a position in RGEN in Q2 2025 and has held it in 2 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • American Capital Advisory held 3 shares of Repligen worth $354 as of Q1 2026.
  • Repligen was a new American Capital Advisory position in Q1 2026.
  • Repligen made up ﹤0.01% of American Capital Advisory's portfolio in Q1 2026, its #931 holding.
  • American Capital Advisory first reported a position in Repligen in Q2 2025 and has held it in 2 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on American Capital Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.